blog image

m-RESIST: The vision which became a reality!

The m-RESIST Final Review will be held on February 20, 2018, at the EC premises in Brussels, to validate project results and achievements. This three-year project (2015- 2017), of more than 3 million euros, developed an innovative disease management system focused on the needs of patients with Treatment-Resistant Schizophrenia, studying new therapeutic protocols and disease management methods based on mobile technologies.

blog image

4th Plenary Meeting, Oulu (Finland)

On 7th, 8th & 9th of June 2016, the EC co-funded project m-RESIST had its 4th Plenary Meeting in Oulu. The meeting was hosted by the University of Oulu, Medical Faculty. Project partners came together in order to plan subsequent steps and align individual tasks and approaches. All partners attended this consortium meeting.

We will use this space to keep you updated about project developments as well as things to do in the field of mHealth. So stay tuned

blog image

ICIC16 – 16th International Conference on Integrated Care, Barcelona

m-RESIST Oral Poster,  “An innovative and integrative m-Health solution for treatment resistant schizophrenia patients” will be presented by MSc Anna Alonso (Spain) on  25 May 2016 at  the 16th International Conference on Integrated Care (ICIC16) that will be held in Barcelona, Spain. 

blog image

EPA 2016

m-RESIST will be presented during the Symposium “Lifespan development of schizophrenia and how the treatments improve outcome”, chaired by Professor emeritus Matti Isohanni (Finland) during the European Congress of Psychiatry (EPA 2016), that will be held on 12 – 15 March 2016, in Madrid, Spain. During the symposium the following presentations will take place:

“Treatment-resistant schizophrenia during life span: epidemiology, outcomes and innovative m-Health treatments within m-RESIST project” by MA Katya Rubinstein (Israel).

Subscribe to RSS - mHealth